October 31, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Shionogi to Acquire U.S. Drug Maker Sciele Pharma
 

Tokyo, Sept 1, 2008 (Jiji Press) - Major Japanese drug maker Shionogi & Co. <4507> said Monday that it will acquire Sciele Pharma Inc. of the United States through a tender offer.

Shionogi will pay 31 dollars for each Sciele Pharma share in the tender offer, which will be launched within 10 days, at a total cost of 1,424 million dollars. The tender offer will last for 20 business days, Shionogi said.

Shionogi is aiming to make the Atlanta-based company a fully owned unit.

Sciele Pharma has strength in drugs for treating high cholesterol and high blood pressure, and has more than 700 medical representatives.

The company posted sales of 382 million dollars in 2007, up from the preceding year's 293 million dollars, and a net profit of 45 million dollars, unchanged.

At a press conference, Shionogi President Isao Teshirogi praised Sciele Pharma for its strong marketing capabilities.

Shionogi is aiming to take advantage of Sciele Pharma's network in boosting sales in the United States while concentrating its own business resources there on research and development activities.

Japanese drug makers are beefing up their overseas operations through business acquisitions in the face of slowing growth in the domestic market.

Earlier this year, Takeda Pharmaceutical Co. <4502> announced its plan to acquire Millennium Pharmaceuticals Inc. of the United States. Daiichi Sankyo Co. <4568> is set to buy Indian drug giant Ranbaxy Laboratories Ltd.

By Jiji Press, (c) Jiji Press

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Daiichi Sankyo  News  
  Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria  (Aug 1, 2013)
  Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy  (Feb 15, 2013)
  Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign  (Dec 20, 2012)
  Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania  (Sept 2, 2009)
  Daiichi Sankyo Files Application for Dysuria Treatment KMD-3213 in China  (Jan 8, 2009)
  Daiichi Sankyo and Ranbaxy Move Forward Toward The Completion of the Landmark Deal  (Oct 20, 2008)
  Daiichi Sankyo's Tender Offer for Ranbaxy Ends in Success  (Oct 17, 2008)
  Shionogi to Acquire U.S. Drug Maker Sciele Pharma  (Sept 1, 2008)
  Daiichi Sankyo to Buy Indian Drug Giant Ranbaxy  (June 11, 2008)
  Daiichi Sankyo to Acquire German Biomedical Firm  (May 21, 2008)



 Recent  Drugs & OTC News   
Otsuka's 'QuickNavi-Flu' Diagnostic Kit to Provide Additional Diagnosis-Related Information (Oct 14, 2014)
Nitto Denko Anti-fibrosis Drug Starts Phase-1b Dosing for Cirrhosis Patients in the US (Oct 10, 2014)
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)

More Drugs & OTC news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)